Welcome to our dedicated page for Roadzen SEC filings (Ticker: RDZN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Roadzen, Inc. (Nasdaq: RDZN), an insurance technology and AI company focused on auto insurance and mobility. Through these filings, investors can review Roadzen’s financial results, capital structure, material agreements, and corporate actions in detail.
Roadzen uses current reports on Form 8-K to disclose material events such as quarterly and annual financial results, equity offerings, convertible note issuances, and senior secured debt arrangements. For example, the company has reported registered offerings of ordinary shares under a shelf registration statement on Form S-3, private placements with institutional investors, and the issuance of junior convertible notes. It has also filed 8-Ks describing agreements in principle and extensions of its senior secured notes with Mizuho Securities USA LLC.
Filings also document Roadzen’s mergers and acquisitions activity, including definitive agreements and closings for majority control of commercial auto insurance brokers and Managing General Underwriters in the U.S., as well as mandates to manage insurance programs for major automakers. These disclosures outline transaction structures, licensing footprints, and expected revenue contributions, giving context to Roadzen’s expansion in commercial auto and embedded insurance.
Annual and quarterly reports referenced in these filings provide additional information on revenue, gross margins, net loss, adjusted EBITDA, and key operating metrics such as customer agreements, claims volumes, and gross written premium. On Stock Titan, AI-powered tools can help summarize lengthy documents like 10-K and 10-Q reports, highlight key terms in 8-Ks, and surface notable items in exhibits and agreements. Users can also track Form 4 insider transaction filings, when available, to see how executives and significant shareholders transact in RDZN shares and related securities.
By combining real-time EDGAR updates with AI-generated summaries, this page helps investors quickly understand Roadzen’s regulatory disclosures, financing activities, and strategic transactions without reading every filing line by line.
Roadzen Inc. director Adhikari Saurav received a new stock option grant. On 09/15/2025, he was awarded stock options to purchase 152,732 ordinary shares at an exercise price of $2 per share. The options were acquired at a price of $0 and are exercisable starting 09/15/2025, with an expiration date of 09/15/2032. Following this grant, he beneficially owns 152,732 derivative securities directly.
Roadzen Inc. entered a securities purchase agreement with an institutional investor to issue junior convertible notes with up to an aggregate principal amount of $5,555,555. The notes were sold for a gross purchase price of $5,000,000, bear interest at 14% per annum and mature on June 20, 2027, with the rate rising to 18% upon an event of default. Quarterly payments of $925,000 of principal plus accrued interest begin three months after issuance. The notes are convertible into ordinary shares at an initial conversion price of $3.50 per share, subject to adjustment and a beneficial ownership cap starting at 4.99%, which holders may increase up to 9.99% with advance notice. Roadzen may redeem the notes early by paying principal, accrued interest and a make‑whole amount, and agreed to covenants restricting additional indebtedness and certain equity or equity‑linked issuances. The company also amended junior convertible notes issued in November 2025 to add cross‑default and related covenants linked to the new notes.
Roadzen Inc. is offering $5,555,555 aggregate principal amount of junior convertible notes that are convertible into its ordinary shares. The notes are sold at an approximately 10% original issue discount, providing gross proceeds of $5,000,000 and estimated net proceeds of about $4.9 million after expenses.
The notes mature on June 20, 2027, carry 14% annual interest that increases to 18% if an event of default occurs, and require quarterly payments of $925,000 or the then-outstanding principal plus accrued amounts. They are initially convertible at $3.50 per share, subject to anti-dilution adjustments and 4.99%–9.99% beneficial ownership limits, and may be redeemed by the company if specific conditions are met.
Roadzen plans to use the proceeds mainly to repay payables and higher-cost debt, including secured 2022 debentures bearing 19.25%–20% interest, and for general corporate purposes. The company discloses substantial doubt about its ability to continue as a going concern and warns of significant risks, including debt service burdens, potential dilution from future equity, no trading market for the notes, possible PFIC-related tax consequences for U.S. holders, and the possibility that investors may lose all of their investment.
Roadzen Inc. director Zoe Ashcroft reported a new stock option award. On 09/15/2025, she was granted 152,732 stock options to buy Roadzen ordinary shares at an exercise price of $2 per share. These options become exercisable on 09/15/2025 and are scheduled to expire on 09/15/2032. Following this grant, she beneficially owns 152,732 derivative securities, held directly.
Roadzen Inc. director Steven J. Carlson reported an award of 267,281 stock options with a $2 exercise price on September 15, 2025. The options are exercisable starting September 15, 2025 and expire on September 15, 2032, each tied to one ordinary share. Following this grant, he beneficially owns 267,281 derivative securities directly.
Roadzen Inc. director Supurna VedBrat reported receiving a new stock option grant. On 09/15/2025, VedBrat was granted a stock option to buy 152,732 Roadzen ordinary shares at an exercise price of $2.00 per share. The option became exercisable on 09/15/2025 and will expire on 09/15/2032. Following this grant, VedBrat beneficially owned 152,732 derivative securities directly.
Roadzen Inc. director Ajay Shah reported a new stock option grant for 152,732 derivative securities. On 09/15/2025, he was awarded a stock option (right to buy) covering 152,732 ordinary shares at a conversion or exercise price of $2 per share. The option becomes exercisable on 09/15/2025 and expires on 09/15/2032. Following this transaction, Shah beneficially owned 152,732 derivative securities directly.
Roadzen Inc. director Diane Beth Glossman reported a new stock option grant. On September 15, 2025, she was awarded 190,915 stock options giving her the right to buy up to 190,915 ordinary shares. The options have an exercise price of $2 per share, were first exercisable on September 15, 2025, and expire on September 15, 2032. The Form 4 shows she now directly holds 190,915 derivative securities following this grant, and the options were granted at no cash cost to her.
Roadzen Inc. insider Rohan Malhotra, who serves as Chief Executive Officer, director and a 10% owner, reported buying 10,000 ordinary shares on 12/04/2025 at a weighted average price of $1.71 per share. These trades were executed in multiple transactions between $1.70 and $1.71.
After this purchase, Malhotra directly holds 829,837 ordinary shares. He is also deemed to beneficially own 17,577,213 ordinary shares held by Avacara Pte Ltd and 45,854 ordinary shares held by RM Securities LLC, while disclaiming beneficial ownership except for his pecuniary interest. In addition, he holds 5,616,485 ordinary shares underlying restricted stock units that are scheduled to fully vest on September 17, 2026, subject to his continuous service with Roadzen.